Scientists have uncovered a hidden driver of ovarian cancer—high-risk mesenchymal stem cells lurking in the fallopian tubes.
News-Medical.Net on MSN11d
Pitt study uncovers a novel trigger of deadly form of ovarian cancerResearchers at the University of Pittsburgh have identified a novel trigger of a deadly form of ovarian cancer: a subset of ...
Ernexa Therapeutics embarks on new strategic direction, shifting the company’s focus from delivering a cell therapy platform to prioritizing ...
December 2024, immediately following the approval of the world's first mesenchymal stromal cells clinical trial, the U.S. FDA ...
Mesoblast Limited ( ($AU:MSB) ) has provided an announcement. Mesoblast Limited announced that its CEO, Silviu Itescu, will ...
Honey isn't just for sweetening your tea—it’s a skincare powerhouse! 🍯 Guerlain’s new Abeille Royale Youth Watery Oil Serum ...
Researchers to showcase research into neonatal brain repair at the PREMSTEM Conference from 13 to 15 May 2025 in Barcelona, ...
Researcher suggests compounds secreted by high-risk MSCs that are detectable in the bloodstream could act as biomarkers for ...
A transformative study has uncovered the pivotal role of the protein Naked cuticle homolog 2 (NKD2) in regulating the differentiation of bone-forming osteoblasts and bone-resorbing osteoclasts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback